@article{a2f18da6e59f4dba8e4cd6d5b889e6bd,
title = "Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”",
keywords = "Hepatocellular carcinoma, Immunotherapy, Predictive biomarker, Tumor immune microenvironment",
author = "Hiroaki Kanzaki and Yujin Hoshida",
year = "2025",
month = jan,
doi = "10.3350/CMH.2024.0886",
language = "English",
volume = "31",
pages = "e121--e122",
journal = "Clinical and Molecular Hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "1",
}